Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, September 30, 2025.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2025 (2025-09-30): -118.08%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-138.95%
RETURN ON EQUITY (ROE) AVG 3Y
-164.24%
RETURN ON EQUITY (ROE) AVG 5Y
-112.00%
RETURN ON EQUITY (ROE) AVG 10Y
-97.76%
RETURN ON EQUITY (ROE) AVG 15Y
-72.38%
RETURN ON EQUITY (ROE) AVG 20Y
-59.17%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
IM Cannabis Corp.
Market Cap
$1.15M
Return on Equity (ROE)
N/A
TTM Avg
-138.95%
3Y Avg
-164.24%
5Y Avg
-112.00%
Market Cap
$1.14M
Return on Equity (ROE)
-200.63%
TTM Avg
-312.18%
3Y Avg
-122.70%
5Y Avg
-56.14%
Market Cap
$1.10M
Return on Equity (ROE)
-11.85%
TTM Avg
-6.20%
3Y Avg
47.36%
5Y Avg
47.36%
Market Cap
$1.07M
Return on Equity (ROE)
-57.87%
TTM Avg
-222.45%
3Y Avg
-164.72%
5Y Avg
-135.78%
Market Cap
$1.25M
Return on Equity (ROE)
N/A
TTM Avg
206.72%
3Y Avg
141.32%
5Y Avg
115.74%
Market Cap
$1.03M
Return on Equity (ROE)
-93.97%
TTM Avg
234.49%
3Y Avg
123.23%
5Y Avg
1171.22%
Market Cap
$1.32M
Return on Equity (ROE)
-114.48%
TTM Avg
-127.66%
3Y Avg
-155.08%
5Y Avg
-465.16%
Market Cap
$1.34M
Return on Equity (ROE)
-111.51%
TTM Avg
-753.43%
3Y Avg
-507.39%
5Y Avg
-356.28%
Market Cap
$1.38M
Return on Equity (ROE)
-253.57%
TTM Avg
334.28%
3Y Avg
134.39%
5Y Avg
95.16%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.15M | N/A | -138.95% | -164.24% | -112.00% |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.14M | -200.63% | -312.18% | -122.70% | -56.14% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -11.85% | -6.20% | 47.36% | 47.36% |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | -57.87% | -222.45% | -164.72% | -135.78% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.25M | N/A | 206.72% | 141.32% | 115.74% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -93.97% | 234.49% | 123.23% | 1171.22% |
| NewcelX Ltd. (NCEL)vs › | $1.32M | -114.48% | -127.66% | -155.08% | -465.16% |
| Genprex, Inc. (GNPX)vs › | $1.34M | -111.51% | -753.43% | -507.39% | -356.28% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | -253.57% | 334.28% | 134.39% | 95.16% |
| GlucoTrack, Inc. (GCTK)vs › | $881948.00 | N/A | -255.88% | -273.58% | -200.54% |
ROE
N/A
ROA
-65.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-09-30 | -118.08% |
| 2025-06-30 | -54.89% |
| 2025-03-31 | -92.13% |
| 2024-12-31 | -212.93% |
| 2024-09-30 | -216.73% |
| 2024-06-30 | -201.95% |
| 2024-03-31 | -153.87% |
| 2023-12-31 | -67.00% |
| 2023-09-30 | -206.94% |
| 2023-06-30 | -760.24% |
| 2023-03-31 | -754.23% |
| 2022-12-31 | -831.78% |
| 2022-09-30 | -317.91% |
| 2022-06-30 | -26.01% |
| 2022-03-31 | -16.10% |
| 2021-12-31 | -8.86% |
| 2021-09-30 | -11.55% |
| 2021-06-30 | -13.26% |
| 2021-03-31 | -19.62% |
| 2020-12-31 | -253.20% |
| 2020-09-30 | -24.91% |
| 2020-06-30 | -35.60% |
| 2018-04-30 | -1.11% |
| 2018-01-31 | -0.41% |
| 2015-01-31 | -10.43% |
| 2014-10-31 | -8.26% |
| 2014-07-31 | -7.17% |
| 2014-04-30 | -7.51% |
| 2014-01-31 | -175.05% |
| 2013-10-31 | -163.24% |
| 2013-07-31 | -164.65% |
| 2013-04-30 | -161.09% |
| 2013-01-31 | -3.92% |
| 2012-10-31 | -3.96% |
| 2012-07-31 | -4.55% |
| 2012-04-30 | -6.04% |
| 2012-01-31 | -7.34% |
| 2011-10-31 | -7.69% |
| 2011-07-31 | -8.27% |
| 2011-04-30 | -7.21% |
| 2011-01-31 | -8.60% |
| 2010-10-31 | -15.00% |
| 2010-07-31 | -13.99% |
| 2010-04-30 | -14.22% |
| 2010-01-31 | -13.55% |
| 2009-10-31 | -12.41% |
| 2009-07-31 | -9.75% |
| 2009-04-30 | -24.55% |
| 2009-01-31 | -23.43% |
| 2008-10-31 | -24.65% |
| 2008-07-31 | -22.70% |
| 2008-04-30 | -31.26% |
| 2008-01-31 | -43.37% |
| 2007-10-31 | -60.99% |
| 2007-07-31 | -63.61% |
| 2007-04-30 | -41.75% |
| 2007-01-31 | -53.65% |
| 2006-10-31 | -90.55% |
| 2006-07-31 | -82.99% |
| 2006-04-30 | -99.23% |
| 2006-01-31 | -149.09% |
| 2005-10-31 | -50.92% |
| 2005-07-31 | -2.53% |
| 2005-04-30 | 1.05% |
| 2005-01-31 | 39.18% |
| 2004-10-31 | -7.41% |
| 2004-07-31 | -94.11% |
| 2004-04-30 | -90.13% |
| 2004-01-31 | -124.02% |
| 2003-10-31 | -31.09% |
| 2003-07-31 | -342.88% |
